Abera Bioscience AB is a Swedish biotechnology company specializing in the research and development of novel vaccine candidates. They utilize their proprietary BERA platform technology, which enables the display of multiple antigens on the surface of microbial hosts, aiming to induce broad and strong immune responses. Abera's primary focus is on developing vaccines for diseases with significant unmet medical needs, including pneumococcal infections and other bacterial and viral diseases. The company actively progresses its pipeline through preclinical and early clinical development stages, often in collaboration with academic and industry partners.
The headquarters serves as the primary center for research and development, strategic planning, corporate administration, and business development activities.
Located within Medicon Village, a prominent life science park offering state-of-the-art laboratory facilities, office spaces, and a collaborative ecosystem with other biotech companies and research organizations.
The work culture is likely highly scientific, innovative, and collaborative, driven by a mission to develop impactful vaccines. Being part of Medicon Village encourages networking and knowledge sharing.
Its location in Medicon Village provides access to advanced research infrastructure, a skilled talent pool, and opportunities for collaboration crucial for a biotech R&D company.
While Abera Bioscience AB's physical operations are primarily based at its headquarters in Lund, Sweden, its impact and collaborations are global. The company engages with international partners for research, clinical trials, and potential commercialization of its vaccine candidates. Its investor base is also international, reflecting its listing on the Spotlight Stock Market. Their target markets for vaccines are worldwide, addressing global health needs.
Medicon Village, Scheeletorget 1
Lund
Skåne County
Sweden
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Abera Bioscience AB' leadership includes:
Abera Bioscience AB has been backed by several prominent investors over the years, including:
Based on publicly available information, the core executive team of Abera Bioscience AB has remained stable over the past 12 months with no major publicly announced hires or departures at the top executive level (CEO, CFO, CSO). Focus has been on R&D progress.
Discover the tools Abera Bioscience AB uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Abera Bioscience AB likely utilizes common professional email formats. Based on industry standards and the company's domain, the most probable format involves a combination of the employee's first name and last name.
firstname.lastname@aberabio.com
Format
maria.alriksson@aberabio.com
Example
80%
Success rate
Abera Bioscience / Cision • April 25, 2024
Abera Bioscience announced promising results from a preclinical study where its chlamydia vaccine candidate demonstrated a significantly strengthened and broader immune response, including in the genital tract mucosa....more
Abera Bioscience / Cision • April 10, 2024
The US Patent Office (USPTO) has issued a Notice of Allowance for Abera's patent application covering its platform technology BERA and its universal vaccine candidate against pneumococci, Ab-01.12....more
Abera Bioscience / Cision • February 15, 2024
Abera Bioscience released its year-end financial report for 2023, detailing its financial performance and operational highlights, including progress in its vaccine development programs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Abera Bioscience AB, are just a search away.